Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 04:11, 12 November 2019
   
Page name:

11 November 2019

 m   23:10  Esophageal cancer‎‎ (2 changes | history) . . (+844). . [Jwarner‎ (2×)]
 m    23:10 (cur | prev) . . (+854). . Jwarner (talk | contribs)
 m    09:30 (cur | prev) . . (-10). . Jwarner (talk | contribs)

10 November 2019

 m   22:43  Rectal cancer‎ (diff | hist) . . (+426). . Jwarner (talk | contribs)
 m   22:41  Cholangiocarcinoma‎ (diff | hist) . . (+140). . Jwarner (talk | contribs)
 m   22:35  Anal cancer‎ (diff | hist) . . (+106). . Jwarner (talk | contribs)
 m   14:57  Colon cancer‎ (diff | hist) . . (+3,379). . Jwarner (talk | contribs)

9 November 2019

 m   10:21  Cervical cancer‎ (diff | hist) . . (+709). . Jwarner (talk | contribs)

8 November 2019

 m   22:05  Pancreatic cancer‎ (diff | hist) . . (+345). . Jwarner (talk | contribs)

7 November 2019

     23:15  Gastric cancer‎‎ (10 changes | history) . . (+6,810). . [Ivyabraham‎ (3×); Jwarner‎ (7×)]
 m    23:15 (cur | prev) . . (+181). . Jwarner (talk | contribs) (Metastatic or locally advanced disease, subsequent lines of therapy)
 m    23:10 (cur | prev) . . (+1,443). . Jwarner (talk | contribs) (S-1 monotherapy {{#subobject:a12a2a|Regimen=1}})
 m    23:09 (cur | prev) . . (-1,443). . Jwarner (talk | contribs) (Pembrolizumab monotherapy)
 m    23:09 (cur | prev) . . (+2,506). . Jwarner (talk | contribs) (Cisplatin & Fluorouracil {{#subobject:4d9936|Regimen=1}})
 m    23:05 (cur | prev) . . (-1,173). . Jwarner (talk | contribs) (Pembrolizumab + Cisplatin + 5-FU)
 m    23:00 (cur | prev) . . (0). . Jwarner (talk | contribs) (Pembrolizumab Monotherapy)
 m    22:59 (cur | prev) . . (+302). . Jwarner (talk | contribs) (Pembrolizumab Monotherapy)
      22:39 (cur | prev) . . (+39). . Ivyabraham (talk | contribs) (Regimen #subobject:82ca03) (Tag: Visual edit)
      22:36 (cur | prev) . . (+1,565). . Ivyabraham (talk | contribs) (Added docetaxel + S-1 as adjuvant therapy option based on 2019 ASCO abstract) (Tag: Visual edit)
      22:16 (cur | prev) . . (+3,390). . Ivyabraham (talk | contribs) (Regorafenib monotherapy #subobject:022ef0) (Tag: Visual edit)
 m   17:38  Cholangiocarcinoma‎ (diff | hist) . . (+8). . Jwarner (talk | contribs) (Ivosidenib {{#subobject:af0357|Regimen=1}})
 m   17:21  Colon cancer‎‎ (2 changes | history) . . (+522). . [Jwarner‎ (2×)]
 m    17:21 (cur | prev) . . (+64). . Jwarner (talk | contribs)
 m    07:45 (cur | prev) . . (+458). . Jwarner (talk | contribs)

5 November 2019

     16:37  Cholangiocarcinoma‎ (diff | hist) . . (+1,552). . Ariseifter (talk | contribs) (Added ivosidenib (phase III) for IDH1 mutation. Presented at ESMO last month, not yet indexed on pubmed as far as I could see.) (Tag: Visual edit)